Addressing Mentorship, Research, and Career Development: A Panel Discussion for Trainees
Monday, April 29, 2024 at 12:00 pm Eastern | Via Zoom
This panel will feature four panelists discussing topics relevant to all students and trainees in pathology and laboratory medicine. Topics will include mentorship, research, and career development.
Panelists:
Dr. Elizabeth Stone
Dr. Elizabeth Stone is an Assistant Professor of Pathology & Cell Biology at Columbia University, where she practices Transfusion Medicine at Columbia University Irving Medical Center as an Assistant Attending and is the Medical Director of Clinical Pathology at NewYork-Presbyterian Westchester. As a Principal Investigator in the Laboratory of Transfusion Biology, Dr. Stone has pioneered a mouse model for platelet transfusion with interest in optimizing platelet transfusion storage and outcomes. Dr. Stone is also an active clinical educator across Divisions and Departments at Columbia University to promote best transfusion practices across the NewYork-Presbyterian enterprise, and she was awarded the Joseph Fink Teaching Award for her resident teaching. She currently serves on the Board for BBANYS as Secretary, is the co-chair of the BBANYS Education Committee, and is chairing the 2024 BBANYS Annual Meeting.
Dr. Tayler van den Akker
Dr. Tayler van den Akker holds an academic appointment in the Department of Pathology at the Icahn School of Medicine at Mount Sinai as assistant professor. She is also Assistant Medical Director of Blood Bank and Transfusion Medicine at Mount Sinai Hospital. She completed her residency in Anatomic and Clinical Pathology at Mount Sinai followed by fellowships in Hematopathology and Transfusion Medicine/Blood Banking at New York Presbyterian/Weill-Cornell Medical Center and Johns Hopkins Hospital, respectively.
Dr. Matthew Elkins
Matthew completed his MD and PhD at the University of Illinois-Urbana-Champaign and completed his AP/CP pathology residency and Transfusion Medicine/Blood Banking fellowship at the University of Michigan. He is the Transfusion Medicine Director, Director of Apheresis, Stem Cell Laboratory Associate Director, Medical Director of Chemistry, and Director of the Upstate Cord Blood Bank. In addition to these clinical roles, he serves as the Pathology Department Quality Officer and chairs three institutional quality committees. He is the Director of the SUNY Upstate Transfusion Medicine/Blood Banking fellowship and Associate Director of the SUNY Upstate Pathology residency program. Matthew is a dedicated educator and proponent for interdepartmental and inter-institutional collaboration for best clinician learning as well as patient care.
Dr. Majed RefaaiDr. Refaai is a Professor of Pathology and Laboratory Medicine at the University of Rochester Medical Center, Rochester, NY. At Strong Memorial Hospital, he serves as the Director of the Thrombosis and Hemostasis Lab and the Associate Director of the Blood Bank/Transfusion Medicine Department and the Clinical Laboratory Department, and he holds an appointment as an Associate Director of the Therapeutic Apheresis Unit in the Internal Medicine/Hematology Department. Dr. Refaai is also the medical director of two CSL plasma centers in upstate NY.
Dr. Refaai received his medical degree from the Aleppo University School of Medicine in Syria. He then joined Massachusetts General Hospital-Harvard Medical School in Boston as a research fellow in a special coagulation research lab. Dr. Refaai completed a residency in clinical pathology at the Washington University School of Medicine in St. Louis, MO and held a fellowship in transfusion medicine at the University of Texas Southwestern in Dallas, TX.
His research focuses on the in vitro and in vivo effects of ABO antibodies and ABO immuno-complexes on platelet function, coagulation processes, and endothelial cell integrity. Dr. Refaai is also working on developing a platelet micro-particles lysate that can be used to control bleeding. This product has been patented. Another patent that Dr. Refaai is developing currently is an ABO point-of-care testing device.
He is also involved in pharmaceutical clinical trials of emergency reversal of coagulopathy, as well as treatments for deep vein thrombosis and thrombotic thrombocytopenic purpura. Dr. Refaai is board-certified in clinical pathology and has published more than 140 peer reviewed articles and book chapters.
Registration:
Free and open to members and non-members.
Please register in advance for this session. After registering, you will receive a confirmation email containing information about joining the session via Zoom.
Contact us at bbanys@bbanys.org if you have any questions.
